We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant Glioblastomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00463073
Recruitment Status : Completed
First Posted : April 20, 2007
Last Update Posted : December 11, 2008
Sponsor:
Collaborators:
Information provided by:

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2008
  Study Completion Date : December 2008